Therapeutic antibodies targeting angiomotin inhibit angiogenesis in vivo

FASEB Journal

Volumn 22, Issue 3, 2008, Pages 880-889

  Levchenko, Tetyana ^a   Veitonmäki, Niina ^a,d   Lundkvist, Andrea ^c   Gerhardt, Holger ^c   Ming, Yue ^b   Berggren, Kristina ^d   Kvanta, Anders ^b   Carlsson, Roland ^d   Holmgren, Lars ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ST ERIK S EYE HOSPITAL   (Sweden)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d Bioinvent Int AB   (Sweden)

Author keywords

Angiostatin; Migration; Neoplasia; Vascular ocular disease

Indexed keywords

ANGIOMOTIN; ANGIOMOTIN ANTIBODY; ANGIOSTATIN; FIBROBLAST GROWTH FACTOR 2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B06; MONOCLONAL ANTIBODY CT17; PROTEIN; RECOMBINANT ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTIBODY ENGINEERING; ANTIGEN BINDING; ARTICLE; CELL ASSAY; CELL COUNT; CELL MIGRATION; CELL STRAIN HEK293; CELL SURFACE; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RETINA BLOOD VESSEL; SUBRETINAL NEOVASCULARIZATION; TUMOR GROWTH;

ANIMALS; ANTIBODIES, MONOCLONAL; AORTA; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICROFILAMENT PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PSEUDOPODIA; RECOMBINANT PROTEINS; RETINA;

DANIO RERIO;

EID: 40449086341     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-9509com     Document Type: Article

References (37)